Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E V Shih"'
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 7-8, Pp 34-39 (2020)
Tricyclic antidepressants, not influencing the P450 3A4 activity, are safe in combination with drugs of other groups used in the treatment of comorbid patients. Azaphen is is one of the agents most widely used in the clinical practice. The in vitro e
Externí odkaz:
https://doaj.org/article/66c9d559bec84f47b9c76efcba54f4ac
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 17, Iss 3, Pp 22-26 (2018)
Aim. To evaluate a complex clinical efficacy, tolerability and safety of statin drugs — simvastatin, atorvastatin, rosuvastatin in patients with hyperlipidemia (HL).Material and methods. The assessment of clinical efficacy was done in 90 patients w
Externí odkaz:
https://doaj.org/article/9418df9e5d2a40cbb440252c902373c2
Autor:
N.A. Rumyantsev, N. B. Lazareva, O A Goroshko, V.F. Marinin, M. V. Zhuravleva, A S Zhestovskaia, V V Smirnov, G.V. Ramenskaya, E V Shih, A B Prokofiev, Kukes Vg, Yu V Olefir, D V Mandich
Publikováno v:
Clinical Medicine (Russian Journal). 95:197-200
Personalized medicine - a new direction in medicine, which is based on the study of various biomarkers and the use of new methods of molecular analysis (primarily evaluating the activity of isoenzymes of cytochrome P450), allowing individualized appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b47b7905a354fd0544b251b0ec5707a
https://doi.org/10.18821/0023-2149-2017-95-3-197-200
https://doi.org/10.18821/0023-2149-2017-95-3-197-200
Publikováno v:
Kardiologiia. (10)
In this article we have described clinical pharmacology and data of clinical studies of an innovational drug valsartan + sacubitril in patients with chronic heart failure (CHF). The use of supramolecular complex valsartan + sacubitril allows to eleva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e1763ed345cae648ddeab33d47e182a
https://pubmed.ncbi.nlm.nih.gov/30359220
https://pubmed.ncbi.nlm.nih.gov/30359220
Autor:
V G, Kukes, V F, Marinin, Yu V, Olefir, G V, Ramenskaya, N B, Lazareva, V V, Smirnov, M V, Zhuravleva, A B, Prokofiev, E V, Shih, A S, Zhestovskaia, N A, Rumyantsev, D V, Mandich, O A, Goroshko
Publikováno v:
Klinicheskaia meditsina. 95(3)
Personalized medicine - a new direction in medicine, which is based on the study of various biomarkers and the use of new methods of molecular analysis (primarily evaluating the activity of isoenzymes of cytochrome P450), allowing individualized appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ddd02c48fdc15f8dd376b4bc595ee65
https://pubmed.ncbi.nlm.nih.gov/30303336
https://pubmed.ncbi.nlm.nih.gov/30303336
Publikováno v:
Scopus-Elsevier
In this article we have described clinical pharmacology and data of clinical studies of an innovational drug valsartan + sacubitril in patients with chronic heart failure (CHF). The use of supramolecular complex valsartan + sacubitril allows to eleva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::093b74f2ec1be768ec21140dbc69f6e7
http://www.scopus.com/inward/record.url?eid=2-s2.0-85055622733&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85055622733&partnerID=MN8TOARS
